Global, Regional and National Burden of Bladder Cancer, 1990 to 2016: Results from the GBD Study 2016.
Adult
Aged
Cause of Death
Cohort Studies
Disability Evaluation
Female
Global Health
Humans
Life Expectancy
Male
Middle Aged
Neoplasm Invasiveness
/ pathology
Neoplasm Staging
Quality-Adjusted Life Years
Registries
Retrospective Studies
Risk Assessment
Smoking
/ adverse effects
Survival Analysis
Tumor Burden
Urinary Bladder Neoplasms
/ diagnosis
blood glucose
cigarette smoking
global burden of disease
mortality
urinary bladder neoplasms
Journal
The Journal of urology
ISSN: 1527-3792
Titre abrégé: J Urol
Pays: United States
ID NLM: 0376374
Informations de publication
Date de publication:
05 2019
05 2019
Historique:
pubmed:
25
1
2019
medline:
30
5
2019
entrez:
25
1
2019
Statut:
ppublish
Résumé
Bladder cancer is among the leading causes of cancer death worldwide. Data on the bladder cancer burden are valuable for policy-making. We aimed to estimate the burden of bladder cancer by country, age group, gender and sociodemographic status between 1990 and 2016. Data from vital registration systems and cancer registries were the input to estimate the bladder cancer burden. Mortality was estimated in an ensemble model approach, incidence was estimated by dividing mortality by the mortality-to-incidence ratio and prevalence was estimated using the mortality-to-incidence ratio as a surrogate for survival. We modeled the years lived with disability using disability weights of bladder cancer sequelae. Years of life lost were calculated by multiplying the number of deaths by age by the standard life expectancy at that age. Disability adjusted life-years were calculated by summing the years lived with disability and the years of life lost. Moreover, we also estimated the burden attributable to bladder cancer risk factors, smoking and high fasting plasma glucose using the comparative risk assessment framework of the Global Burden of Disease study. In 2016 there were 437,442 incident cases (95% UI 426,709-447,912) of bladder cancer with an age standardized incidence rate of 6.69/100,000 (95% UI 6.52-6.85). Bladder cancer led to 186,199 deaths (95% UI 180,453-191,686) in 2016 with an age standardized rate of 2.94/100,000 (95% UI 2.85-3.03). Bladder cancer was responsible for 3,315,186 disability adjusted life-years (95% UI 3,193,248-3,425,530) in 2016 with an age standardized rate of 49.45/100,000 (95% UI 47.68-51.11). Of bladder cancer deaths 26.84% (95% UI 19.78-33.91) and 7.29% (95% UI 1.49-16.19) were due to smoking and high fasting glucose, respectively, in 2016. Although the number of bladder cancer incident cases is growing globally, the age standardized incidence and number of deaths are decreasing, as mirrored by a decreasing smoking contribution.
Identifiants
pubmed: 30676477
doi: 10.1097/JU.0000000000000025
doi:
Types de publication
Comparative Study
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
893-901Commentaires et corrections
Type : CommentIn